First published in 2009 and revised in 2016, the American College of Clinical Pharmacy (ACCP) Pharmacotherapy Didactic Curriculum Toolkit is a key resource used by schools and colleges of pharmacy to guide the design and improvement of pharmacotherapy curricula.^1-3 A 2019 update to the toolkit developed by the 2019 ACCP Publications Committee is now available in pre-publication.⁴

The 2019 edition of the pharmacotherapy didactic toolkit retains the competency-based tier designations and definitions introduced in the previous edition. The three tiers are as follows:

• Tier 1: Students receive education and training on this topic to prepare them to provide collaborative, patient-centered care upon graduation and licensure.
• Tier 2: Students receive education and training on this topic, but additional knowledge or skills may be required after graduation (e.g., residency training or equivalent experience) to prepare them to provide collaborative, direct patient care.
• Tier 3: Students and residents may not receive education and training on this topic; rather, they will be expected to obtain the required knowledge and skills on their own to provide collaborative, direct patient care if required in their practice.

Updates to the toolkit reflect advances in the scientific understanding of the various conditions and diseases, newly approved drugs, and the pharmacist’s role in providing direct care to patients with these conditions and diseases.

The 2019 edition of the toolkit comprises 302 topics: 94 (31%) tier 1, 133 (44%) tier 2, and 75 (25%) tier 3 entries. In identifying the list and tier designation for each condition and disease included in the toolkit, emphasis is placed on those for which pharmacotherapy management is an option and requires the expertise of the practicing pharmacist. The complete list of diseases and conditions and their tier designations are available at www.accp.com/docs/positions/misc/Flannery_et_al-2019-Journal_of_the_American_College_of_Clinical_Pharmacy.pdf.